CING Latest Press Releases

-- August 13, 2026 --

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness Globe Newswire 8:30 AM

-- August 11, 2026 --

Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301's Differentiated Pharmacokinetic Profile Globe Newswire 8:30 AM

-- July 30, 2026 --

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology Globe Newswire 8:30 AM

-- July 2, 2026 --

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E Globe Newswire 8:30 AM

-- June 16, 2026 --

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301 Globe Newswire 8:00 AM

-- June 2, 2026 --

Cingulate Receives Complete Response Letter from FDA for CTx-1301 Globe Newswire 8:00 AM

-- May 14, 2026 --

Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301 Globe Newswire 8:00 AM

-- March 18, 2026 --

Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software